The safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy (Q36945003)

17 August 2017

1 reference

title

The safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy (English)

1 reference

17 August 2017

John A Almeida

1

1 reference

17 August 2017

Stephen M Riordan

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Expert Opinion on Drug Safety

17 August 2017

published in

1 reference

17 August 2017

volume

6

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

493-503

1 reference

Birth outcome following maternal use of metoclopramide. The Euromap study group

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Use of antiemetic drugs during pregnancy in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Antacids. Indications and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

The irritable bowel syndrome during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Paroxetine (Paxil) and congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Neonate characteristics after maternal use of antidepressants in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Birth outcomes after prenatal exposure to antidepressant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

The obstetrical patient with a prosthetic heart valve

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Population-based case control study of the safety of sulfasalazine use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Sulphasalazine and male infertility: reversibility and possible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Corticosteroids during pregnancy and oral clefts: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Maternal corticosteroid use and risk of selected congenital anomalies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Immunosuppression in pregnancy: choices for infant and maternal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Pregnancy in recipients of solid organs--effects on mother and child

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Pregnancy after liver transplantation under tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Analysis of 100 pregnancy outcomes in women treated systemically with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Adalimumab use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

No evidence for mutagenic effects of ribavirin: report of two normal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Conception soon after discontinuing interferon/ribavirin therapy: a successful outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Treating hypertension in women of child-bearing age and during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Epidural fentanyl in labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Respiratory muscle rigidity in a preterm infant after use of fentanyl during Caesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Which induction drug for cesarean section? A comparison of thiopental sodium, propofol, and midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Neurobehavioural effects of propofol on the neonate following elective caesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Intravenous propofol vs thiamylal-isoflurane for caesarean section, comparative maternal and neonatal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

Augmentin treatment during pregnancy and the prevalence of congenital abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.6.5.493

21 January 2018

Identifiers

DOI

10.1517/14740338.6.5.493

1 reference

17 August 2017

1 reference